Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Quanome Technologies, Inc. (QNME)

Quanome Technologies sets up $9.75 million at-the-market stock sale program with Maxim

Neutral Impact 3 of 5 financing Written later

Quanome Technologies entered an At The Market Offering Agreement with Maxim Group LLC that lets the company sell up to $9,754,475 of common stock through the agent over time. The company has no obligation to sell any shares, and actual proceeds, if any, are not determinable at this time, so the filing signals potential dilution rather than a completed raise.

Key points

  • Maximum aggregate offering price of up to $9,754,475 of common stock, sold through Maxim Group LLC as agent or principal
  • Company pays a 3.0% cash transaction fee on gross sales, plus legal expense reimbursement capped at $40,000
  • Shares would be sold under a Form S-3 shelf registration effective October 16, 2026; net proceeds intended for working capital, general corporate purposes and potential acquisitions

The filing

CompanyQuanome Technologies, Inc. (QNME)
Form8-K, current report
Filed with the SECOct 21, 2026, 4:25 PM ET
Accession number0001213900-26-111358

Items reported: 1.01 Material Definitive Agreement

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 21, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.